<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Beachler DC</submitter><funding>National Institute of Allergy and Infectious Disease</funding><funding>NIDCR NIH HHS</funding><funding>NCATS NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>National Institute of Dental and Craniofacial Research</funding><funding>PHS HHS</funding><pagination>1588-91</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4621250</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>212(10)</volume><pubmed_abstract>The association between oral human papillomavirus 16 (HPV16) DNA load and infection clearance was evaluated among 88 individuals with oral HPV16 infection who were identified within a prospective cohort of 1470 HIV-infected and uninfected individuals. Oral rinse specimens were collected semiannually for up to 5 years. The oral HPV16 load at the time of the first positive test result was significantly associated with the time to clearance of infection (continuous P trends &lt;.01). Notably, clearance rates by 24 months were 41% and 94% in the highest and lowest HPV16 load tertiles (P = .03), respectively. High oral HPV16 load warrants consideration as a biomarker for infection persistence, the presumed precursor of HPV16-associated oropharyngeal cancer.</pubmed_abstract><journal>The Journal of infectious diseases</journal><pubmed_title>High Oral Human Papillomavirus Type 16 Load Predicts Long-term Persistence in Individuals With or at Risk for HIV Infection.</pubmed_title><pmcid>PMC4621250</pmcid><funding_grant_id>T32 CA CA009314</funding_grant_id><funding_grant_id>T32 CA009314</funding_grant_id><funding_grant_id>U01-AI35039</funding_grant_id><funding_grant_id>U01-AI-031834</funding_grant_id><funding_grant_id>U01-A1-35043</funding_grant_id><funding_grant_id>U01-AI-042590</funding_grant_id><funding_grant_id>U01 AI031834</funding_grant_id><funding_grant_id>UL1 TR000424</funding_grant_id><funding_grant_id>UM1 AI035043</funding_grant_id><funding_grant_id>U01 AI035004</funding_grant_id><funding_grant_id>U01 AI034993</funding_grant_id><funding_grant_id>UL1-TR000424</funding_grant_id><funding_grant_id>U01 AI035039</funding_grant_id><funding_grant_id>R01 DE021395</funding_grant_id><funding_grant_id>U01-AI-034993</funding_grant_id><funding_grant_id>U01 AI035041</funding_grant_id><funding_grant_id>U01 AI035042</funding_grant_id><funding_grant_id>UM1-AI35043</funding_grant_id><funding_grant_id>U01 AI042590</funding_grant_id><funding_grant_id>U01-AI35042</funding_grant_id><funding_grant_id>U01-AI35041</funding_grant_id><pubmed_authors>Beachler DC</pubmed_authors><pubmed_authors>Guo Y</pubmed_authors><pubmed_authors>Margolick JB</pubmed_authors><pubmed_authors>Jacobson LP</pubmed_authors><pubmed_authors>Xiao W</pubmed_authors><pubmed_authors>Sugar EA</pubmed_authors><pubmed_authors>D'Souza G</pubmed_authors><pubmed_authors>Reddy S</pubmed_authors><pubmed_authors>Gillison ML</pubmed_authors><pubmed_authors>Weber KM</pubmed_authors><pubmed_authors>Cranston RD</pubmed_authors><pubmed_authors>Minkoff H</pubmed_authors><pubmed_authors>Strickler HD</pubmed_authors><pubmed_authors>Wiley DJ</pubmed_authors><pubmed_authors>Burk RD</pubmed_authors></additional><is_claimable>false</is_claimable><name>High Oral Human Papillomavirus Type 16 Load Predicts Long-term Persistence in Individuals With or at Risk for HIV Infection.</name><description>The association between oral human papillomavirus 16 (HPV16) DNA load and infection clearance was evaluated among 88 individuals with oral HPV16 infection who were identified within a prospective cohort of 1470 HIV-infected and uninfected individuals. Oral rinse specimens were collected semiannually for up to 5 years. The oral HPV16 load at the time of the first positive test result was significantly associated with the time to clearance of infection (continuous P trends &lt;.01). Notably, clearance rates by 24 months were 41% and 94% in the highest and lowest HPV16 load tertiles (P = .03), respectively. High oral HPV16 load warrants consideration as a biomarker for infection persistence, the presumed precursor of HPV16-associated oropharyngeal cancer.</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Nov</publication><modification>2025-04-22T21:21:15.035Z</modification><creation>2019-03-27T02:00:48Z</creation></dates><accession>S-EPMC4621250</accession><cross_references><pubmed>25954049</pubmed><doi>10.1093/infdis/jiv273</doi></cross_references></HashMap>